Posts in Government

Raskin Presses Squires on Motives for Board of Peace Trademark Filings

On Tuesday, May 5, Representative Jamie Raskin (D-MD), Ranking Member of the House Judiciary Committee, sent a letter to U.S. Patent and Trademark Office (USPTO) Director John Squires pressing him to answer questions about the Office’s role in filing a trademark application on behalf of the Trump Administration for Trump’s “Board of Peace.”

Google’s Challenge to PTAB Limits Puts Reliance and Balance on the Line

In its recent petition to the U.S. Supreme Court, Google argues that patents can be invalid at any time, even decades after issuance, and therefore should remain open to inter partes review (IPR) challenges, regardless of age or how long they have been relied upon. At first glance, this sounds like a defense of patent quality. Coming from one of the most frequent users of the Patent Trial and Appeal board (PTAB) over the past decade — and arriving just as the U.S. Patent and Trademark Office’s (USPTO’s) “settled expectations” doctrine begins to limit late-stage IPR challenges — it raises a sharper question: why now?

As Congress Considers PERA, It Should Allow the Frustrated Inventor to Be Heard

A person recently approached me at church with excitement regarding a software process he developed. His company was so pleased with the result that it is filing a patent, listing him as the inventor. This person knew that I had some kind of patent backstory, so he asked for my thoughts. My name is Jeffrey A. Killian, and I am the patent applicant in the Federal Circuit Court case # 2021 -2113 (In Re: Killian). I took no pleasure in telling my  friend at church that his patent application will be rejected. Plus, the official notice will have my precedential case quoted all over his rejection. With friends at church like me, who needs enemies? 

EU Returns to Special 301 Report’s Watch List for First Time Since 2006

On April 30, the Office of the U.S. Trade Representative (USTR) released this year’s Special 301 Report, which surveys the effectiveness of intellectual property (IP) rights and enforcement abroad and identifies foreign nations where IP protections are uncertain or disregarded. The 2026 report marks the first time in 13 years that a Priority Foreign Country (PFC) has been named, with Vietnam being identified as a PFC for persistent failures to address several long-standing IP concerns. The USTR has also added the European Union (EU) to the Special 301 Report’s Watch List, the first time since 2006 that the continental government has been identified for IP-related concerns in addition to individual European nations.

What the USPTO’s Reexamination Remand for HID Means for Estoppel, Timing and Strategy

The U.S. Patent and Trademark Office (USPTO) issued a significant Decision on Remand on Monday, April 27, 2026, clarifying when estoppel under 35 U.S.C. § 315(e)(1) attaches and—critically—what it means to “request” a proceeding “before the Office.” The ruling arises from an increasingly common set of circumstances—HID had initially filed an inter partes review (IPR) against CPC Patent Technologies’ U.S. Patent No. 9,665,705, and subsequently requested ex parte reexamination requests of that same patent. Monday’s decision clarifies that a party is estopped from “requesting” ex parte reexam at the moment the IPR final written decision issues when the USPTO has yet to order ex parte reexam.

UNC Charlotte Highlights the Power of Invention at 2026 Invention of the Year Awards

The University of North Carolina at Charlotte brought together leaders from government, academia, industry, and the defense community for its 2026 Invention of the Year Awards, an evening that showcased the university’s growing role as a national engine of innovation, commercialization, and technological impact.

The Latest Attempt to Expose SAWS Highlights Structural Flaws at the USPTO

Whether or not the United States Patent and Trademark Office (USPTO) wants to admit it, over most of the last generation there has been a secret examination docket. Not surprisingly, such a secret examination docket is strictly prohibited by federal law. A newly filed joint status report in Morinville v. USPTO brings this issue to the fore and underscores the lack of transparency and accountability of secret internal patent review programs at the USPTO. Procedurally, the latest filing seeks to expose the USPTO shadow docket through a new round of discovery, which is currently being considered by the United States District Court for the District of Columbia.

Hot Takes: What the Oral Arguments in Hikma/ Amarin Revealed

The Supreme Court heard oral arguments yesterday in Hikma Pharmaceuticals USA v. Amarin Pharma, Inc., a case with broad implications for the generic industry’s practice of “skinny labeling” and the induced infringement standard for patent law and beyond. IPWatchdog reached out to members of the IP community for their initial takeaways from yesterday’s arguments.

Federal Circuit Vacates PTAB Obviousness Determination and Holds Real Party in Interest Challenge Unreviewable

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a precedential decision Wednesday in Federal Express Corporation v. Qualcomm Incorporated, vacating a determination by the United States Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB) that certain claims of a Federal Express Corporation patent were unpatentable as obvious. The CAFC also held that it could not review the PTAB’s refusal to determine whether all real parties in interest were identified in the petition for inter partes review (IPR).

Justices Voice Concern that Upholding CAFC’s Hikma ‘Skinny Label’ Ruling Will Harm Generics Industry

The U.S. Supreme Court heard oral arguments today in Hikma v. Amarin, a closely-watched case that in part asks the Justices to weigh in on whether a drugmaker calling its product a “generic version” while citing public sales information about the branded drug induces infringement of a patented use fully carved out by the generic’s label. Hikma’s petition also asks whether a complaint states an induced infringement claim if it fails to allege any instruction or statement by the defendant mentioning the patented use. While some Justices today questioned why the case was even before them, others seemed concerned about the potential impact of the case for the generic pharmaceutical industry.

Operationalizing AI: From Passenger Experience to Orbital Logistics

Welcome back to Cool AI Patents of the Month, where we highlight innovations that blur the line between science fiction and real-world engineering. Last month, we looked at AI-generated voice replicas, particularly in sports broadcasting. That concept is no longer theoretical. Major League Baseball players have reportedly entered into agreements enabling the creation of AI-driven digital avatars, allowing fans to engage directly with AI-generated versions of their favorite players. The takeaway is clear: personality and likeness are being productized. What once seemed futuristic is quickly becoming commercially relevant.

World IP Day 2026 Spotlights IP Issues in Sports

The World Intellectual Property Organization (WIPO) established World IP Day to commemorate April 26, 1970, the date the WIPO Convention officially took effect. Each year, the occasion serves as a global reminder of the role that intellectual property plays in encouraging innovation and creativity. This year, the World IP Day theme is “IP and Sports Ready, Set, Innovate,” recognizing the increasingly complex relationship between intellectual property rights and the multibillion-dollar global sports industry.

Federal Circuit In Part Reverses PTAB Ruling that Some Centripetal Network Threat Detection Patent Claims are Non-Obvious

The U.S. Court of Appeals for the Federal Circuit (CAFC) issued a decision Tuesday in Centripetal Networks, LLC v. Keysight Technologies, Inc., affirming in part and reversing in part a decision of the United States Patent and Trademark Office’s (USPTO) Patent Trial and Appeal Board (PTAB). The CAFC determined that the PTAB correctly found claims 1 through 3, 5 through 13, and 15 through 20 of Centripetal Networks, LLC’s patent directed to network threat detection unpatentable for obviousness. The court reversed the PTAB’s determination regarding claims 4 and 14, finding those claims unpatentable for obviousness as well.

Broader Concerns Over AI Emerge in Senate Judiciary Hearing on Chinese IP Theft

China was not the only actor being scrutinized today during a full Senate Judiciary Committee hearing, titled “Stealth Stealing: China’s Ongoing Theft of U.S. Innovation.”  Senator Thom Tillis (R-NC) stood in for Senator Chuck Grassley (R-IA) as Chair and opened the hearing with a warning that, in addition to its blatant IP theft—which is estimated to cost the United States between $400 billion and $600 billion per year—China is more recently evolving from “imitator to innovator.” “The United States must overcome its historic and ideological views that China is unable to innovate,” Tillis said.

Congress is Lagging on Innovation Policy; Americans Are Paying the Price

Intellectual property (IP) protections don’t merely shield Americans’ ideas and designs from theft—they underpin our entire economy and standard of living. Approximately 90% of the market value of the S&P 500 is in intangible assets, based on IP. Weakened IP protections erode American prosperity and human potential as IP-intensive industries support 63 million U.S. jobs and account for over 40% of America’s economic output.

Varsity Sponsors

Industry Events

Certified Patent Valuation Analyst Training
May 28 @ 9:00 am - May 29 @ 5:00 pm EDT
2026 WIPO-U.S. Summer School on Intellectual Property
June 1 @ 9:00 am - June 12 @ 1:45 pm EDT

From IPWatchdog